This text is a result of machine translation.
In the half year, the 36billion yuan production expansion plan has been thrown away, and the competition in the stock market of Baijiu is fierce
Synthetic Biology: Who Will Emerge as the Winner?
The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.
Jun 27, 2022 12:38 PM
Research
AutomotiveFinancing and Investment Activities in China's Mobility Industry From 2012 to 2022
Dongbei group: the holding foundry subsidiary currently produces brake discs and other products at full capacity, with orders in short supply
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Cro plate fell, and Wuxi apptec fell nearly 10%
How Can Solar Companies Seize Opportunities in the Post-Subsidy Era?
Oct 10, 2024 05:23 PM
Mexicans Who Can’t Afford Tacos Flock to Chinese Restaurants
Oct 08, 2024 11:11 AM